Maarten F. Schim van der Loeff

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active

CONTROL: CONTROL: effectiviteit & optimalisatie van bron- en contactonderzoek om de verspreiding van SARS-CoV-2 te beperken
Matser, A. & Schim van der Loeff, M. F.
1/09/2020 → 1/04/2023
Project: Research

34 Article
1 Comment/Letter to the editor
1 Editorial
1 Review article

Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples
Wijstma, E. S., Jongen, V. W., Alberts, C. J., de Melker, H. E., Hoes, J. & Schim van der Loeff, M. F., 1 Jan 2023, In: Epidemiology (Cambridge, Mass.). 34, 1, p. 119-130 12 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies
Wei, F., Goodman, M. T., Xia, N., Zhang, J., Giuliano, A. R., D'Souza, G., Hessol, N. A., Schim van der Loeff, M. F., Dai, J., Neukam, K., de Pokomandy, A., Poynten, I. M., Geskus, R. B., Burgos, J., Etienney, I., Moscicki, A-B., Donà, M. G., Gillison, M. L., Nyitray, A. G., Nowak, R. G., & 18 othersYunihastuti, E., Zou, H., Hidalgo-Tenorio, C., Phanuphak, N., Molina, J-M., Schofield, A. M., Kerr, S., Fan, S., Lu, Y., Ong, J. J., Chikandiwa, A. T., Teeraananchai, S., Squillace, N., Wiley, D. J., Palefsky, J. M., Georges, D., Alberts, C. J. & Clifford, G. M., 8 Feb 2023, In: Clinical Infectious Diseases. 76, 3, p. e692-e701
Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study
Campman, S. L., van Rossem, G., Boyd, A., Coyer, L., Schinkel, J., Agyemang, C., Galenkamp, H., Koopman, A. D. M., Leenstra, T., Schim van der Loeff, M., Moll van Charante, E. P., van den Born, B-J. H., Lok, A., Verhoeff, A., Zwinderman, A. H., Jurriaans, S., Stronks, K. & Prins, M., 17 Mar 2023, In: Vaccine. 41, 12, p. 2035-2045 11 p.
Research output: Contribution to journal › Article › Academic › peer-review
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study
AGEhIV Cohort Study, Mar 2023, In: Lancet HIV. 10, 3, p. e164-e174
Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study: Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
The Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative & Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative, 18 May 2022, (E-pub ahead of print) In: Sexually Transmitted Infections.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

1 Citation (Scopus)

Maarten F. Schim van der Loeff

Network

Dive into details

CONTROL: CONTROL: effectiviteit & optimalisatie van bron- en contactonderzoek om de verspreiding van SARS-CoV-2 te beperken

Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples

Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies

Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study

Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study

Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study: Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study

Maarten F. Schim van der Loeff

Network

Projects

CONTROL: CONTROL: effectiviteit & optimalisatie van bron- en contactonderzoek om de verspreiding van SARS-CoV-2 te beperken

Research output

Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples

Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies

Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study

Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study

Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study: Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study